Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Garber

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Plos One|July 1, 2022
Assumptions about patients seeking PrEP: Exploring the effects of patient and sexual partner race and gender identity and the moderating role of implicit racismSamuel R Bunting, Brian A Feinstein, Sarah K Calabrese, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1993
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitorM J Otto, C D Reid, S Garber, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S Pan, J A Markwalder, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 proteaseM J Otto, S Garber, D L Winslow, et al.
Clinical Radiology|November 1, 1989
Non-operative management of gallstones--a preliminary reviewS N Jones, W R Lees, S Garber, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|November 1, 1992
A transformed human epithelial cell line that retains tight junctions post crisisA L Cozens, M J Yezzi, M Yamaya, et al.
LGBT Health|April 11, 2022
Evaluating Medical Students' Views of the Complexity of Sexual Minority Patients and Implications for CareSamuel R Bunting, Sarah K Calabrese, Sabina T Spigner, et al.
Chemistry & Biology|January 5, 2002
Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV proteaseC A Chen, S M Sieburth, A Glekas, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitorsM Patel, R F Kaltenbach, D A Nugiel, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variantsR F Kaltenbach, G Trainor, D Getman, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Plos One|July 1, 2022
Assumptions about patients seeking PrEP: Exploring the effects of patient and sexual partner race and gender identity and the moderating role of implicit racismSamuel R Bunting, Brian A Feinstein, Sarah K Calabrese, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1993
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitorM J Otto, C D Reid, S Garber, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S Pan, J A Markwalder, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 proteaseM J Otto, S Garber, D L Winslow, et al.
Clinical Radiology|November 1, 1989
Non-operative management of gallstones--a preliminary reviewS N Jones, W R Lees, S Garber, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|November 1, 1992
A transformed human epithelial cell line that retains tight junctions post crisisA L Cozens, M J Yezzi, M Yamaya, et al.
LGBT Health|April 11, 2022
Evaluating Medical Students' Views of the Complexity of Sexual Minority Patients and Implications for CareSamuel R Bunting, Sarah K Calabrese, Sabina T Spigner, et al.
Chemistry & Biology|January 5, 2002
Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV proteaseC A Chen, S M Sieburth, A Glekas, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitorsM Patel, R F Kaltenbach, D A Nugiel, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variantsR F Kaltenbach, G Trainor, D Getman, et al.
Pageof 9